Nautilus Biotechnolgy share price logo

Nautilus Biotechnolgy

NASDAQ: NAUT

$0.90

-0.01

(-1.59%)

as on

Nautilus Biotechnolgy Stock Performance

as on September 7, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.89
    $0.95
    downward going graph

    1.11%

    Downside

    5.56%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.65
    $4.31
    downward going graph

    27.54%

    Downside

    378.90%

    Upside

    downward going graph

Nautilus Biotechnolgy share price movements today

Previous Close
$0.92
Open
$0.93
Volume
668.9K
Market Cap
$115.0M
Day's Low - High
$0.89 - $0.95
52 Week Low - High
$0.65 - $4.31

Nautilus Biotechnolgy Historical Returns

1 Month Return
+ 0.53 %
3 Month Return
-62.14 %
1 Year Return
+ 36.9 %
3 Year Return
-71.72 %
5 Year Return
-87.92 %

Nautilus Biotechnolgy Stock Fundamentals & Key Indicators

Check Nautilus Biotechnolgy market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$115.0M

EPS (TTM)

-0.45

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.01

Industry PE ratio

-1.61

PEG Ratio

-0.13529607960796072

EBITDA

-55.0M

Revenue (TTM)

190.0K

Profit Margin

-919.47%

Return On Equity TTM

-37.58%

Nautilus Biotechnolgy Stock Valuation

Track how Nautilus Biotechnolgy P/E has moved over time to understand its valuation trends.

Nautilus Biotechnolgy in the last 5 years

  • Overview

  • Trends

Lowest (-8.70x)

December 31, 2021

Today (-4.15x)

December 31, 2025

Industry (-1.61x)

December 31, 2025

Highest (-3.00x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -4.15x

Nautilus Biotechnolgy vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nautilus Biotechnolgy with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$115.0M-87.92%-2.01-919.47%NA
BUY$44.6B614.61%NA0.00%NA
BUY$138.4B184.14%31.5386.04%NA
BUY$58.1B-66.65%-18.24-12.57%NA
BUY$85.2B23.76%19.7684.86%0.44999999999999996%

Stock Returns calculator for Nautilus Biotechnolgy Stock including INR - Dollar returns

The Nautilus Biotechnolgy stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Nautilus Biotechnolgy investment value today

Current value as on today

₹1,46,224

Returns

₹46,224

(+46.22%)

Returns from Nautilus Biotechnolgy Stock

₹36,157 (+36.16%)

Dollar Impact

₹10,066 (+10.07%)

Analyst Recommendation on Nautilus Biotechnolgy Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Nautilus Biotechnolgy. Average target price of $4

Nautilus Biotechnolgy Share Price Target

Get share price movements and forecasts by analysts on Nautilus Biotechnolgy.

What analysts predicted

77.5%UPSIDE

Target Price

$4

Current Price

$0.9

Analyzed by

1 Analysts

Target

$4.00

Nautilus Biotechnolgy target price $4, a slight upside of 77.5% compared to current price of $0.9. According to 1 analysts rating.

Indian Investors' Interest in Nautilus Biotechnolgy Stock

Search interest for Nautilus Biotechnolgy Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

Nautilus Biotechnolgy Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
0
Gross Profit
-1
-1
-1
-6
-
-
-
-1
-1
1
Operating Income
-21
-20
-19
-19
-18
-17
-15
-15
-16
-15
EBITDA
-17
-16
-14
-11
-17
-15
-13
-12
-13
-15
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
6
1
1
1
1
1
-
Income Before Tax
-18
-18
-16
-17
-16
-15
-13
-13
-14
-14
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-18
-18
-16
-17
-16
-15
-13
-13
-14
-14
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
693.16%

Nautilus Biotechnolgy Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
-
-2
-2
-
-5
-6
-6
Operating Income
-111
-10
-15
-50
-63
-76
-81
-66
EBITDA
626
-9
-13
-47
-60
-61
-64
-52
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
738
0
2
2
3
1
6
6
Income Before Tax
626
-9
-15
-50
-57
-63
-70
-59
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
626
-9
-15
-50
-57
-63
-70
-59
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Nautilus Biotechnolgy Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-18
-18
-16
-17
-16
-15
-13
-13
-14
-14
Operating Cash Flow
-16
-15
-13
-14
-13
-13
-11
-12
-13
-13
Investing Cash Flow
22
14
-7
37
19
14
0
0
14
12
Financing Cash Flow
0
0
0
0
0
0
-
0
1
0
Change in Cash
6
0
-20
23
5
1
-10
-11
2
-1

Nautilus Biotechnolgy Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
626
-9
-15
-50
-57
-63
-70
-59
Operating Cash Flow
-238
-9
-13
-39
-45
-51
-59
-50
Investing Cash Flow
1
4
-25
-138
-25
-43
66
35
Financing Cash Flow
145,186
0
75
327
0
0
1
0
Change in Cash
1
0
36
149
-70
-95
8
-15

Mutual Funds that own Nautilus Biotechnolgy Stock

Check out the Mutual Funds with significant holdings in Nautilus Biotechnolgy.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
1.931809%
2458329
Fidelity Concord Street Trust
0.372356%
473843
TIAA-CREF Funds
0.128229%
163179
Bridgeway Funds, Inc.
0.102156%
130000
DFA INVESTMENT DIMENSIONS GROUP INC
0.085235%
108467

Global Institutional Holdings in Nautilus Biotechnolgy

Funds
Holdings
Joseph Edelman
9.14%
Vanguard
2.21%
iShares
1.31%
Bridgeway
0.06%
Dimensional
0.04%

Insights on Nautilus Biotechnolgy

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 35.2% return, outperforming this stock by 107.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 486.2% return, outperforming this stock by 457.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, NAUT stock has moved down by -61.2%

About Nautilus Biotechnolgy

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.
OrganisationNautilus Biotechnolgy
Headquarters2701 Eastlake Avenue East, Seattle, WA, United States, 98102
IndustryBiotechnology
CEOMr. Sujal M. Patel
E-voting on sharesClick here to vote

Key Management of Nautilus Biotechnolgy

Name

Title

Ms. Anna Mowry

CFO & Treasurer

Mr. Matthew B. Murphy ESQ.

General Counsel

Ms. Amber Faust

Vice President of Global Sales

Ms. Jamie Rose Kuhar Ph.D.

Vice President of Marketing

Ms. Gwen E. Weld

Chief People Officer

Dr. Subra Sankar Ph.D.

Senior Vice President of Product Development

Mr. Sujal M. Patel

Co-Founder, CEO, President, Secretary & Director

Dr. Parag Mallick Ph.D.

Co-Founder, Chief Scientist & Director

FAQs

What is Nautilus Biotechnolgy share price today?

Nautilus Biotechnolgy share price today is $0.90 as on at the close of the market. Nautilus Biotechnolgy share today touched a day high of $0.95 and a low of $0.89.

What is the 52 week high and 52 week low for Nautilus Biotechnolgy share?

Nautilus Biotechnolgy share touched a 52 week high of $4.31 on and a 52 week low of $0.65 on . Nautilus Biotechnolgy stock price today i.e. is closed at $0.90,which is 79.12% down from its 52 week high and 38.02% up from its 52 week low.

What is Nautilus Biotechnolgy's market capitalisation today?

Nautilus Biotechnolgy market capitalisation is $0.00T as on .

How to invest in Nautilus Biotechnolgy Stock (NAUT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nautilus Biotechnolgy on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nautilus Biotechnolgy Shares that will get you 1.6667 shares as per Nautilus Biotechnolgy share price of $0.90 per share as on September 7, 2026 at 8:46 am IST.

What is the minimum amount required to buy Nautilus Biotechnolgy Stock (NAUT) from India?

Indian investors can start investing in Nautilus Biotechnolgy (NAUT) shares with as little as ₹94.485 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Nautilus Biotechnolgy stock (as per the Rupee-Dollar exchange rate as on ). Based on Nautilus Biotechnolgy share’s latest price of $0.90 as on September 7, 2026 at 8:46 am IST, you will get 11.1111 shares of Nautilus Biotechnolgy. Learn more about fractional shares .

What are the returns that Nautilus Biotechnolgy has given to Indian investors in the last 5 years?

Nautilus Biotechnolgy stock has given -87.92% share price returns and 28.66% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?